1679 |
For: IABP, A Life-Saving Device for Shock Patients |
Stephen G. Ellis |
May. 09. 13 |
1678 |
Case Presentation: Left Main AMI with Shock |
Michael S. Lee |
May. 09. 13 |
1677 |
Impact of Functional Angioplasty to Current Practice: Trends in Clinical Outcomes of PCI with Drug Eluting Stents |
Seung-Jung Park |
May. 09. 13 |
1676 |
Invasive Imaging (IVUS, VH-IVUS and OCT): How I Implement to My Practice? |
Gary S. Mintz |
May. 09. 13 |
1675 |
To Closure or Not to Closure(LAA Closure & PFO Closure) |
Horst Sievert |
May. 09. 13 |
1674 |
Counterpoint: Resisting the Bioabsorbable DES "Bandwagon": A Healthy Dose of Skepticism |
David Joel Cohen |
May. 09. 13 |
1673 |
Featured Lecture: The Gold Standard for PCI Will Be Bioabsorbable DES in 5-10 Years |
Ron Waksman |
May. 09. 13 |
1672 |
Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive |
Adnan Kastrati |
May. 09. 13 |
1671 |
Featured Lecture: The Future Is¡¦ New Anti-platelet Agents (Ticagrelor/Prasugrel), Selective Platelet Function Testing, and Patient-specific DAPT Duration (from 3 Months to Indefinite) |
Matthew Price |
May. 09. 13 |
1670 |
Counterpoint: Surgery Should Be the Dominant Therapy in Multi-Vessel Coronary Disease |
David Paul Taggart |
May. 09. 13 |